Committee
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 106 - 120 of 315
View Chrystia Freeland Profile
Lib. (ON)
The new elements in the pharma space that CETA is going to bring in will not actually have an impact on Canadians for eight years—
View Chrystia Freeland Profile
Lib. (ON)
—so it's important not to have a false sense that when this agreement enters into force, those provisions will immediately enter force.
More broadly, what CETA does highlight is that we need a broader look at Canada's pharma strategy, and that is something that my colleague, the Minister of Health, is doing.
I think it's also worth pointing out and worth Canadians knowing that drug prices in European countries like Germany, France, the U.K., are actually lower than in Canada, so the issue is—
View Chrystia Freeland Profile
Lib. (ON)
As I have said, this is an issue on which we are consulting broadly and that my colleague, the Minister of Health, is working on.
I think it's very important for Canadians to understand that the impact of the new provisions in CETA on drug regulation will not fully take effect for a full eight years from the time that this agreement enters into force. It's important to be truthful with Canadians about that—
View Chrystia Freeland Profile
Lib. (ON)
—and it is very important to appreciate that when it comes to drug prices, our government is very committed to working on that file, and it's important to understand that this is part of a broader drug pricing strategy—
View Chrystia Freeland Profile
Lib. (ON)
It is very important to appreciate—
View Chrystia Freeland Profile
Lib. (ON)
View Chrystia Freeland Profile
Lib. (ON)
As I've said, on the impact of CETA on drug pricing, this agreement has been carefully structured so that the full impact is not felt for a full eight years.
As I think we are all aware, this is a very fast-moving space, particularly when it comes to new developments, when it comes to issues of biologics, when it comes to the trade-off between generic and brand name drugs. Our response to CETA very much needs to be, and will be, embedded in broader work that my colleague, the Minister of Health, is doing on—
View Chrystia Freeland Profile
Lib. (ON)
Results: 106 - 120 of 315 | Page: 8 of 21

|<
<
4
5
6
7
8
9
10
11
12
13
>
>|
Export As: XML CSV RSS

For more data options, please see Open Data